Best CT (computer tomography) cardiologists: TOP 379 doctors

Specializations

Arthroscopic Debridement and Microfracture Surgery

Arthroscopic Meniscectomy Surgery

Arthroscopic Anterior Cruciate Ligament Reconstruction

Arthroplasty (Total Joint Prosthesis) Surgery

Knee, Shoulder, Hip Replacement Surgery

Hallux Valgus Surgery (Toe Deformity)

Trauma Surgery

Soft Tissue Tumoral Mass Excision

Experience

Maraş Budaklı Health Center 1993

İnönü University Research Hospital 1994

Kartal Training and Research Hospital 1995-2000

Private Gül Medicine Ensar Hospital 2002

Gebze Central Hospital 2002-2010

Private Oran Cerrah Medical Center 2010-2018

Hospital Park 2019-2021

Education

Cerrahpaşa Faculty of Medicine

Medical Interests 

Interventional Bronchoscopy 

Respiratory Deficiencies 

Rare diseases of the lung 

Interstitial lung diseases 

Psychoneuroimmunology 

Medical Fitness and nutrition 

Education 

Bachelor’s: Istanbul University / Istanbul Faculty of Medicine / 1988-1997 

Specialization in Medicine: Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / Chest Diseases and Tuberculosis / 2001-2006 The Importance and Value of CA-125 in the Diagnosis of Tuberculosis Pleurisy / Assoc. Sedat Altın - Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital

Experience 

Dr. / Ayazağa MCHFP / 1997-2001 

Assist. Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / 2001-2006 

Res. See. / Hopital St-Marguerite Center Laser / 2004 

Res. See. / University de St-Etienne, Faculte de Medecin, Pneumologie et Oncologie Thoracique / 2005 

Dr. / Bozüyük State Hospital / 2006-2008 

Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Interventional Pulmonology Unit / 2008-2012 

Dr. / Zürich University Faculty of Medicine, Lung Transplantation Unit / 2009-2010 

Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Respiratory Intensive Care Unit / 2010-2012 

Assoc. Dr / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2013- 2017 

Prof. Dr. / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2017-2018 • prof. Dr. / Memorial Bahçelievler Hospital / 2018-2018 

Prof. Dr. Demiroglu Science Un. Faculty of Medicine Chest Diseases USA-Istanbul / 2018-2020 Florence Nightingale Hospital 

Prof. Dr. / Memorial Bahçelievler and Şişli Hospitals / 2020-2021 

Liv Hospital Vadistanbul / 2021 -

Memberships 

European Respiratory Society (ERS) 

European Association of Bronchology and Interventional Pulmonology (EABIP) 

Societé de Pnemologie de langue Française (SPLF) 

Groupe d’Endoscopie de langue française (GELF)

Medical School: Suleyman Demirel University, 2004

Neurosurgery Training: Gazi University, Department of Neurosurgery, 2011

Dr Mehmet Tonge has international and nationwide 32 publications, 12 book chapters, 92 oral and poster presentations and 41 invited lectures, mostly on Stereotactic and Functional Neurosurgery.

Work & Training experience:

2004-2011: Gazi University, Department of Neurosurgery (Residency)

2008: Zurich University Hospital, Department of Neurosurgery (Intraoperative MRI applications), Switzerland

2008: Zurich University Hospital, Department of Neurosurgery: Microneurosurgery, white matter dissection, interventional neuroradiology courses, Switzerland

2011 – 2012: Sinop Ataturk State Hospital, Neurosurgeon

2012 – 2013: Cankiri State Hospital, Neurosurgeon

2013 – 2014: Istanbul Medipol University, Department of Neurosurgery & Gamma Knife Center (Ass Prof)

2013 – now: Maastricht University Neurosurgery & Neuroscience Department (Visiting scientist, PhDc) The Netherlands

2014: Maastricht University, The Netherlands: Deep Brain Stimulation Fellowship 2014-2018: Istanbul Memorial Hospital Neurosurgery: Staff Neurosurgeon

2016-2018: Istanbul Florence Nightingale Hospital (Consultant, Gamma Knife Center)

2018-now: Istanbul Medipol University (Stereotactic & Functional Neurosurgery, Gamma Knife Center) Ass. Prof.)

Dr Mehmet Tonge has completed 4-year cycle EANS (European Association of Neurosurgical Societies) Training courses.

Clinical areas of interest:

• Stereotactic & Functional Neurosurgery

• Surgery for movement disorders

• Gamma Knife Radiosurgery

* Surgery for pain & spasticity

* Psychosurgery

Research areas of interest:

* Deep brain stimulation

• Stereotactic radiosurgery

Dr. Başak Bolluk Kılıç, MD graduated from Ankara University Faculty of Medicine in 2000 as a Medical Doctor.  She completed her specialization training in the Department of Neurology at Ankara University in 2005.

In 2004, she worked as an observer at the Department of Movement Disorders at the University of Barcelona Medical Faculty.  Having started her compulsory service in Kırşehir State Hospital in 2006, Dr.  Başak Bolluk Kılıç, MD worked at Ankara Private Tandoğan Magnet Hospital in 2008, at Çamlıca Erdem Hospital between 2010-2016, at Bilgi University Electroneurophysiology Department between 2013-2017, at Bahçeşehir University Faculty of Medicine between 2017-2018 and at Medical Park between 2016-2018. She worked as an Assistant Professor at Göztepe Hospital.

In September 2018, at Istanbul Medipol University Parkinson's Disease and Movement Disorders Center (PARMER) she created the patients' treatment plans. She provides each patient with the most appropriate personalized medical follow-up and treatment support.

Assoc. Prof.  Nesrin Helvacı Yılmaz graduated from Hacettepe University in 2000 as a Medical Doctor.  She completed her specialty training in the Department of Neurology at Ankara University in 2006.

She started her compulsory service in Mardin Nusaybin State Hospital in 2007.  Nesrin Helvacı Yılmaz continued her duty in Gaziantep 27 December State Hospital in 2008.  She worked as a neurologist at Biophysis Nilüfer Medical Center and Ali Osman Sönmez Oncology Hospital in Bursa between 2010-2011, and at Istanbul Universal Aksaray Hospital between 2011-2012. From October 2012, she started to work as a Doctor Lecturer in Istanbul Medipol University Neurology Department.  Nesrin Helvacı Yılmaz received the title of associate professor in 2021.  In 2015, she worked as an Honorary Observer in Parkinson's Disease and Deep Brain Stimulation (Neuromodulation) at UCL Queen Square Institute of Neurology, National Hospital for Neurology in London.  She took part in many training programs on Deep Brain Stimulation (Neuromodulation) in Turkey and abroad between 2013-2022.

Since September 2018, she has been working as a coordinator for student education in the 5th semester of Neurology. As of December 2022, she has developed treatment plans for patients at Medipol University Istanbul Parkinson's Disease and Movement Disorders Center (PARMER) and provides each patient the most appropriate personal medical follow-up and treatment support.

EDUCATION

Balgrist University, Zurich

• Shoulder and Elbow Observership, Feb 8th - March 23rd, 2023

Bezmialem Vakif University

• Shoulder and Elbow Surgery Fellowship Program, March 1st - July 2nd, 2021

Istanbul Sisli Etfal Research and Training Hospital

• Residency, Orthopaedic Surgery, 2011-2016

Hospital for Special Surgery, USA

• Observership, May 2nd - June 30th, 2016

Istanbul University, Istanbul Faculty of Medicine

• Medical School, 2003–2009

PROFESSIONAL EXPERIENCE

Istanbul Sisli Hamidiye Etfal Research and Training Hospital

• Residency, Orthopaedic Surgery, 2011-2016

Kilis State Hospital

• Orthopaedics Surgeon, 2017-2019

Yedikule Surp Pırgiç Armenian Hospital

• Orthopaedics Surgeon, 2019-2020

Istanbul Sisli Hamidiye Etfal Research and Training Hospital

• Orthopaedics Surgeon, 2020-2024

Medipol Acıbadem Hospital

• Orthopaedics Surgeon, 2024-present

Experience: 

2023 - 

Medipol Bahçelievler 

2017 - 2023

Özel İstinye Üniv. Gaziosmanpaşa Medical Park Hopspital

2015 - 2017

DPÜ Evliya Çelebi Eğitim ve Araştırma Hastanesi

2012 - 2015

Süleyman Demirel Üniversitesi Tıp Fakültesi

2008 - 2011

Kırıkkale Devlet Hastanesi

2007 - 2007

Elazığ Eğitim ve Araştırma Hastanesi

2007 - 2008

Eskişehir Asker Hastanesi

2005 - 2007

Elazığ Karakoçan Devlet Hastanesi

2001 - 2001

Batman Beşiri İkiköprü Sağlık Ocağı

2001 - 2005

Dicle Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı

Education: 

2015

Süleyman Demirel University Faculty of Medicine, Nephrology

2005

Dicle University Faculty of Medicine, Internal Medicine

2000

Ege University, Faculty of Medicine

International Peer-Reviewed Journals:

Title: Prospective Surveillance Study For Risk Factors Of Central Venous Catheter-Related Bloodstream Infections.

• Authors: Hoşoğlu Salih, Akalın Şerife, Kıdır Veysel, Süner Ali, Kayabaşı Hasan, Geyik Mehmet Faruk.
• Journal: American Journal Of Infection Control (2004), 32, 131-134.

Title: Serum C-Reactive Protein (CRP) Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovarian Syndrome, And Effect Of Bicalutamide On Hirsutism, CRP Levels And Insulin Resistance.

• Authors: Bahçeci Mithat, Tuzcu Alpaslan Kemal, Canoruç Naime, Tüzün Ahmet Yekta, Kıdır Veysel, Aslan Çetin.
• Journal: Hormone Research (2004), 62(6), 283-287.

Title: Spontaneous Rupture Of The Spleen In A Hemodialysis Patient.

• Authors: Aldemir Mustafa, Süner Ali, Kıdır Veysel, Balakan Ozan, Çelenk Tahir.
• Journal: European Journal Of General Medicine (2004), 1(3), 51-54.

Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.

• Authors: Usul Soyoral Yasemin, Süner Ali, Kıdır Veysel, Arıtürk Atılgan Zuhal, Balakan Ozan.
• Journal: European Journal Of General Medicine (2004), 1(2), 15-18.

Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.

• Authors: Kıdır Veysel, Balakan Ozan, Süner Ali, İt Dede, Ayyıldız Mehmet Orhan.
• Journal: Uhod-Uluslararası Hematoloji-Onkoloji Dergisi (2005), 15(2), 100-103.

Title: Fenofibrate Treatment In Two Adults With Crigler-Najjar Syndrome Type II.

• Authors: Yılmaz Şerif, Dursun Mehmet, Canoruç Fikri, Kıdır Veysel, Beştaş Remzi.
• Journal: Turkish Journal Of Gastroenterology (2006), 17(1), 62-65.

Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.

• Authors: Süner Ali, Balakan Ozan, Kıdır Veysel, Kara İsmail Hamdi.
• Journal: Uhod-Uluslararası Hematoloji-Onkoloji Dergisi (2006), 16(3), 133-136.

Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.

• Authors: Bayram Dilara, Sezer Mehmet Tuğrul, İnal Salih, Altuntaş Atila, Kıdır Veysel, Orhan Hikmet.
• Journal: Clinical And Experimental Nephrology (2014), 19(3), 443-449.

Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.

• Authors: Kıdır Veysel, Altuntaş Atila, İnal Salih, Değirmenci Bumin, Sezer Mehmet Tuğrul.
• Journal: Therapeutic Apheresis And Dialysis (2014), 18(2), 211-212.

Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.

• Authors: İnal Salih, Ulusal Okyay Gülay, Ulu Memnune Sena, Kıdır Veysel, Altuntaş Atila, Ahsen Ahmet, Ünverdi Selman, Akoğlu Hadim, Yüksel Şeref, Duranay Murat, Sezer Mehmet Tuğrul.
• Journal: Renal Failure (2014), 36(8), 1239-1243.

Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.

• Authors: Kıdır Veysel, Ünverdi Selman, Ahsen Ahmet, Orhan Hikmet, Duranay Murat, İnal Salih, Sezer Mehmet Tuğrul.
• Journal: Journal Of Clinical Laboratory Analysis (2015), 29(4), 294-300.

Scientific Conferences:

Title: The Relationship Between Serum C-Reactive Protein Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovary Syndrome.

• Authors: Bahçeci Mithat, Tuzcu Alpaslan Kemal, Canoruç Naime, Tüzün Ahmet Yekta, Kıdır Veysel, Aslan Çetin.
• Conference: American Association of Clinical Endocrinologists (AACE) 13th Annual Meeting and Clinical Congress, 2004.

Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.

• Authors: Usul Soyoral Yasemin, Süner Ali, Kıdır Veysel, Arıtürk Atılgan Zuhal, Balakan Ozan.
• Conference: European Congress of Cardiology, 2004.

Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.

• Authors: Kıdır Veysel, Balakan Ozan, Süner Ali, İt Dede, Ayyıldız Mehmet Orhan.
• Conference: Turkish National Hematology Congress, 2005.

Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.

• Authors: Süner Ali, Balakan Ozan, Kıdır Veysel, Kara İsmail Hamdi.
• Conference: Turkish National Hematology Congress, 2006.

Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.

• Authors: Bayram Dilara, Sezer Mehmet Tuğrul, İnal Salih, Altuntaş Atila, Kıdır Veysel, Orhan Hikmet.
• Conference: European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, 2014.

Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.

• Authors: Kıdır Veysel, Altuntaş Atila, İnal Salih, Değirmenci Bumin, Sezer Mehmet Tuğrul.
• Conference: European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, 2014.

Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.

• Authors: İnal Salih, Ulusal Okyay Gülay, Ulu Memnune Sena, Kıdır Veysel, Altuntaş Atila, Ahsen Ahmet, Ünverdi Selman, Akoğlu Hadim, Yüksel Şeref, Duranay Murat, Sezer Mehmet Tuğrul.
• Conference: Annual Dialysis Conference, 2014.

Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.

• Authors: Kıdır Veysel, Ünverdi Selman, Ahsen Ahmet, Orhan Hikmet, Duranay Murat, İnal Salih, Sezer Mehmet Tuğrul.
• Conference: European Association for Clinical Chemistry and Laboratory Medicine (EFLM) Congress, 2015.

Experience

2019 – 2019

• University of Insubria, Varese, Italy, 

Insubria University Faculty of Medicine

2015

• MERSİN UNIVERSITY/FACULTY OF MEDICINE, DOCTOR, LECTURER

2013 – 2015

• ANKARA PRIVATE ACIBADEM HOSPITAL

2010 – 2012

• DIYARBAKIR TRAINING AND RESEARCH HOSPITAL,

2002 – 2003

• AYDIN 1ST PRIVATE TRAINING BATTALION
•  

Education

2010

• ANKARA UNIVERSITY FACULTY OF MEDICINE, BRAIN AND SURGERY SPECIALIST

1992

• GAZI UNIVERSITY, FACULTY OF MEDICINE

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education: 

Akdeniz University Faculty of Medicine 

Specialization Training: 

Baskent University Faculty of Medicine. Internal diseases 

Akdeniz University Faculty of Medicine, Gastroenterology Minor 

Worked Institutions: 

Tekirdag State Hospital (Compulsory Service) 

Demiroğlu Bilim University Faculty of Medicine, Gastroenterology 

Medical Interests: 

Endoscopy-Colonoscopy 

ERCP 

Hepatology 

Inflammatory Bowel Diseases 

Liver Transplantation

Experience

2018

Private Istanbul Medipol Hospital

2018

Medipol University Camlica Hospital

2018

Medipol Camlica Hospital

2013 - 2018

Medipol Mega University Hospital

2011 - 2013

Yuzuncu Yil University Hospital

2010 - 2011

Gulhane Military Medical Academy

2010 - 2013

Yuzuncu Yil University Hospital

2010 - 2011

Gulhane Military Medical Academy

2010 - 2011

Gulhane Military Medical Academy

2010 - 2013

Yuzuncu Yil University Faculty of Medicine

2009

University of Toronto SickKids Hospital

2004 - 2008

Private Van-Etfal Pediatric Diseases

1999 - 2004

Yuzuncu Yil University Hospital

Education

2010

Yuzuncu Yil University, Pediatric Nephrology

2004

Yuzuncu Yil University, Pediatrics

1998

Ege University, Faculty of Medicine

Experience

2019 - 2022 Medipol University

2010 Private Nisa Hospital

2008 - 2010 Kaman State Hospital

Education

2008

Istanbul University Cerrahpaşa Faculty of Medicine, Obstetrics and Gynecology

2002

Istanbul University, Istanbul Faculty of Medicine

Experience

2018 - 2022

Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital

2016 - 2018

Diyarbakır Memorial Dicle Hospital Cardiology Clinic

2010 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2010 - 2016

Private Veni Vidi Hospital, Cardiology Clinic Supervisor

2006 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2005 - 2006

Urfa State Hospital

1999 - 2005

Turkey High Specialization Training and Research Hospital

1998 - 1999

Duruca Health Center

Education

2018

Health Sciences University, Cardiology

2010

Dicle University, Department of Cardiology

2005

Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization

1998

Ege University, Faculty of Medicine

Experience

2017
Private Nisa Hospital

2011 - 2017
Yenibosna Private Ilke Hospital

2007 - 2011
Gaziosmanpaşa Private Bilge Hospital

Education

2005
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Ear, Nose, and Throat Diseases

2005
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Ear, Nose, and Throat Diseases

2000
İstanbul University Faculty of Medicine, Medical Education

2000
İstanbul University Faculty of Medicine, Medical Education